欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号MT/H/0620/001
药品名称Lisdexamfetamine Adalvo 10mg/ml oral solution
活性成分
    • lisdexamfetamine dimesylate 10.0 mg/ml
剂型Oral solution
上市许可持有人Adalvo Limited Sir. Temi Zammit Buildings 4 Malta Life Sciences Park Buildings 1 level San Gwann, 3000 Malta
参考成员国 - 产品名称Malta (MT)
Lisdexamfetamine AdAlvo 10mg/ml oral
互认成员国 - 产品名称
    • Greece (GR)
许可日期2024/02/08
最近更新日期2024/11/13
药物ATC编码
    • N06BA12 lisdexamfetamine
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Multiple (Copy) Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase